LONDON MARKET OPEN: Mood switches again after Omicron detected in US Read More
TOP NEWS: GSK says Covid-19 treatment works against Omicron variant Read More
LONDON BRIEFING: GlaxoSmithKline's Covid treatment copes with Omicron Read More
LONDON MARKET PRE-OPEN: GSK-Vir's sotrovimab works against Omicron Read More
LONDON BROKER RATINGS: Hochschild Mining hit with three downgrades Read More
LONDON MARKET CLOSE: Stocks mixed on Europe Covid resurgence fears Read More
LONDON MARKET MIDDAY: FTSE left behind as CAC and DAX hit records Read More
GSK gets USD1 billion US deals; Nucala is approved for three diseases Read More
GlaxoSmithKline Comet trial in Covid vaccine meets primary endpoint Read More
UK dividends calendar - next 7 days Read More
LONDON BROKER RATINGS: Capital & Counties and Shaftesbury get upgrades Read More
LONDON BROKER RATINGS: Bernstein downgrades IAG and Ryanair Read More
LONDON BROKER RATINGS: StanChart and Flutter upped to Buy; THG cut Read More
LONDON BROKER RATINGS: Upgrades for Lloyds Banking and NatWest Read More
IN BRIEF: GSK's ViiV Healthcare survey finds support for HIV regimen Read More
LONDON BROKER RATINGS: Shore Capital raises WPP to Buy from Hold Read More
EXECUTIVE CHANGES: GSK adds scientific heft to board ahead of demerger Read More
TOP NEWS: GSK eyes steady annual payout after solid third quarter Read More
UK earnings, trading statements calendar - next 7 days Read More
LONDON BROKER RATINGS: UBS lifts Fresnillo; Jefferies says buy Drax Read More
